At a glance
- Originator Mercian
- Class Antineoplastics; Antirheumatics; Coumarins; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Granulocyte macrophage colony stimulating factor agonists; Immunomodulators; Interferon gamma stimulants; Interleukin 1-alpha stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer; Rheumatoid arthritis